Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 66

1.

MR-spectroscopy guided target delineation for high-grade gliomas.

Pirzkall A, McKnight TR, Graves EE, Carol MP, Sneed PK, Wara WW, Nelson SJ, Verhey LJ, Larson DA.

Int J Radiat Oncol Biol Phys. 2001 Jul 15;50(4):915-28.

PMID:
11429219
2.

3D MRSI for resected high-grade gliomas before RT: tumor extent according to metabolic activity in relation to MRI.

Pirzkall A, Li X, Oh J, Chang S, Berger MS, Larson DA, Verhey LJ, Dillon WP, Nelson SJ.

Int J Radiat Oncol Biol Phys. 2004 May 1;59(1):126-37.

PMID:
15093908
3.

Metabolic imaging of low-grade gliomas with three-dimensional magnetic resonance spectroscopy.

Pirzkall A, Nelson SJ, McKnight TR, Takahashi MM, Li X, Graves EE, Verhey LJ, Wara WW, Larson DA, Sneed PK.

Int J Radiat Oncol Biol Phys. 2002 Aug 1;53(5):1254-64.

PMID:
12128127
4.

Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy.

Laprie A, Pirzkall A, Haas-Kogan DA, Cha S, Banerjee A, Le TP, Lu Y, Nelson S, McKnight TR.

Int J Radiat Oncol Biol Phys. 2005 May 1;62(1):20-31.

PMID:
15850898
5.

Improved delineation of brain tumors: an automated method for segmentation based on pathologic changes of 1H-MRSI metabolites in gliomas.

Stadlbauer A, Moser E, Gruber S, Buslei R, Nimsky C, Fahlbusch R, Ganslandt O.

Neuroimage. 2004 Oct;23(2):454-61.

PMID:
15488395
6.

[Application of (1)H MR spectroscopic imaging in radiation oncology: choline as a marker for determining the relative probability of tumor progression after radiation of glial brain tumors].

Lichy MP, Bachert P, Hamprecht F, Weber MA, Debus J, Schulz-Ertner D, Schlemmer HP, Kauczor HU.

Rofo. 2006 Jun;178(6):627-33. Epub 2006 May 15. German.

PMID:
16703499
7.

Identification of MRI and 1H MRSI parameters that may predict survival for patients with malignant gliomas.

Li X, Jin H, Lu Y, Oh J, Chang S, Nelson SJ.

NMR Biomed. 2004 Feb;17(1):10-20.

PMID:
15011246
8.

Proton magnetic resonance spectroscopic imaging in newly diagnosed glioblastoma: predictive value for the site of postradiotherapy relapse in a prospective longitudinal study.

Laprie A, Catalaa I, Cassol E, McKnight TR, Berchery D, Marre D, Bachaud JM, Berry I, Moyal EC.

Int J Radiat Oncol Biol Phys. 2008 Mar 1;70(3):773-81. doi: 10.1016/j.ijrobp.2007.10.039.

PMID:
18262090
9.

Correlations between magnetic resonance spectroscopy and image-guided histopathology, with special attention to radiation necrosis.

Rock JP, Hearshen D, Scarpace L, Croteau D, Gutierrez J, Fisher JL, Rosenblum ML, Mikkelsen T.

Neurosurgery. 2002 Oct;51(4):912-9; discussion 919-20.

PMID:
12234397
10.

Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.

Fayed N, Dávila J, Medrano J, Olmos S.

Eur J Radiol. 2008 Sep;67(3):427-33. doi: 10.1016/j.ejrad.2008.02.039. Epub 2008 Apr 28.

PMID:
18442889
11.

Proton magnetic resonance spectroscopic imaging integrated into image-guided surgery: correlation to standard magnetic resonance imaging and tumor cell density.

Ganslandt O, Stadlbauer A, Fahlbusch R, Kamada K, Buslei R, Blumcke I, Moser E, Nimsky C.

Neurosurgery. 2005 Apr;56(2 Suppl):291-8; discussion 291-8.

PMID:
15794826
12.

Combination of single-voxel proton MR spectroscopy and apparent diffusion coefficient calculation in the evaluation of common brain tumors.

Bulakbasi N, Kocaoglu M, Ors F, Tayfun C, Uçöz T.

AJNR Am J Neuroradiol. 2003 Feb;24(2):225-33.

13.

Magnetic resonance spectroscopic imaging-guided brachytherapy for localized prostate cancer.

DiBiase SJ, Hosseinzadeh K, Gullapalli RP, Jacobs SC, Naslund MJ, Sklar GN, Alexander RB, Yu C.

Int J Radiat Oncol Biol Phys. 2002 Feb 1;52(2):429-38. Erratum in: Int J Radiat Oncol Biol Phys. 2004 Nov 1;60(3):1011-2.

PMID:
11872289
14.

Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging.

Law M, Yang S, Wang H, Babb JS, Johnson G, Cha S, Knopp EA, Zagzag D.

AJNR Am J Neuroradiol. 2003 Nov-Dec;24(10):1989-98.

15.
16.
17.

Analysis of the spatial characteristics of metabolic abnormalities in newly diagnosed glioma patients.

Li X, Lu Y, Pirzkall A, McKnight T, Nelson SJ.

J Magn Reson Imaging. 2002 Sep;16(3):229-37.

PMID:
12205577
18.

Proton magnetic resonance spectroscopy of brain tumors correlated with pathology.

Magalhaes A, Godfrey W, Shen Y, Hu J, Smith W.

Acad Radiol. 2005 Jan;12(1):51-7.

PMID:
15691725
19.

Proton magnetic resonance spectroscopic imaging to differentiate between nonneoplastic lesions and brain tumors in children.

Hourani R, Horská A, Albayram S, Brant LJ, Melhem E, Cohen KJ, Burger PC, Weingart JD, Carson B, Wharam MD, Barker PB.

J Magn Reson Imaging. 2006 Feb;23(2):99-107.

PMID:
16374884
20.

[Proton magnetic resonance spectroscopic imaging and other types of metabolic imaging for radiotherapy planning in adult and pediatric high-grade gliomas].

Laprie A.

Cancer Radiother. 2009 Oct;13(6-7):556-61. doi: 10.1016/j.canrad.2009.07.003. Epub 2009 Sep 18. Review. French.

PMID:
19766525

Supplemental Content

Support Center